|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Current assets: | |||||||||
| Cash and cash equivalents | |||||||||
| Accounts receivable, net of allowance for credit losses of $184 and $228 as of September 30, 2023 and December 31, 2022, respectively | |||||||||
| Unbilled receivables | |||||||||
| Prepaid expenses and other current assets | |||||||||
| Total current assets | |||||||||
| Operating lease right-of-use assets | |||||||||
| Property and equipment, net | |||||||||
| Goodwill | |||||||||
| Acquired intangible assets, net | |||||||||
| Other assets | |||||||||
| Total assets | |||||||||
| Liabilities and stockholders' equity | |||||||||
| Current liabilities: | |||||||||
| Accounts payable | |||||||||
| Accrued expenses and other current liabilities | |||||||||
| Contingent consideration liability | |||||||||
| Deferred revenue | |||||||||
| Operating lease liabilities | |||||||||
| Total current liabilities | |||||||||
| Long-term operating lease liabilities | |||||||||
| Deferred income taxes | |||||||||
| Contingent consideration liability, net of current portion | |||||||||
| Deferred revenue, net of current portion | |||||||||
| Other long-term liabilities | |||||||||
| Total liabilities | |||||||||
| Stockholders' equity: | |||||||||
| Common stock, par value $0.001 per share, 650,000,000 shares authorized and 167,864,066 and 166,081,011 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively | |||||||||
| Additional paid-in capital | |||||||||
| Accumulated stockholders'/members’ deficit | |||||||||
| Retained earnings (accumulated deficit) | |||||||||
| Total stockholders' equity | |||||||||
| Total liabilities and stockholders' equity |
Loading...
